Member Info for sharcus

Everytime the bid gets smashed like this one thing's clear: Shorts are getting ****ier which'll be their downfall. Market'll make sure that their few consecutive day buyback window will not happen in the green for hedgies. 80+ upon news'll secure that. Be our guest, keep hitting that bid, see where that gets you.

That is one sharp spike on no news. Intrigued.

Scenario 1:

We get the long-awaited 7am RNS (at least one) on Monday
SP opens at 80+
Bronte shorts another few hundred thou as they think it's a temporary spike
And they keep doing just that every 5p upwards
SP keep climbing geometrically throughout the day
We close silly high (north of 100 for sure)
Completely blown their sharpe ratio, they rush to the exits only too late
SP shoots up to 150+ within days.

Scenario 2:

Same thing but on Tuesday. Just a matter of time really.

Some outfit in Sydney, Australia out of all places would you believe. How on earth did we attract that s*house?

https://whalewisdom.com/filer/bronte-capital-management-pty-ltd#tabshort_positions_link

A new hedge fund appeared on the radar just now:

https://shorttracker.co.uk/company/GB00BJL5BR07/

Became a breakeven trade for some here, due to Oliveira's relentless selling. The only way through those technical ceilings (without + RNSs) is serious II buying but we've not been getting those TR1s. Funny that we see something that smart money all across the globe doesn't yet. My intention's still to hold hard (won't add atm) but feeling like a skipper in stormy sees.

btw, Renaissance hasn't been increasing their shorts, in fact bought back some (maybe all?). Keeping it below that 0.5% threshold gives them anonymity. Their in-house research team must've underlined the immediacy of any/all results.

Porky, until smart money starts building a position and protecting it with countering auto-buys, those relentless auto-sells are hard to beat. Even if you were to get a team of prop traders with Python algos bombarding them in DMA. Not a passive fund but a long-biased hedgie is what we need. Or a prop desk willing to build a significant stake. Haven't seen either thus far (check both the funds and institutions tabs):
https://www.morningstar.com/stocks/xlon/dddd/ownership

So to sum it up:

On 16/07/2020, Oliveira acquires 12.49% of our stock (previous holding being zero), and as on 19/11/2021 his holding is still a massive 8.83%. Not technically a fire sale this by any stretch of the imagination, wouldn't you agree? His selling pace isn't typical of a distressed seller but more a like any other II trimming a very large stake to re-allocate exposure elsewhere or to top up here at a later point should the unimaginable happen (wild cards). He's not dumping a few million shares every week is what I'm saying. If he were to fold; i.e. close his biotech book entirely following that nasty Forte $50m write-off, we would have felt it in our bones here. No seismic shifts, just a modest amount of orderly sales that "he" believes the market can absorb. Hedgies on the other hand are very blatantly carpet-bombing the bid and increasing their short exposure with those relentless ATs. Well, something's gotta give ... and it ain't us hard-headed, stubborn LTHs here. When the RNSs start landing this'll be the mother of all short squeezes (that 92p top test on 8 Nov wasn't it). Hand on tight folks and ride the wave. GLA

Also checked the size of those LBPS trades? Razor thin I tell ya. No big shakes.

Right, from 69.4p we need a 58.5% rally to get us to the placing level but it'll be nothing if spectacular news hits the wires early next week. Just remember that 20 July 2020 Monday rally of Synairgen - a whopping 552% in one day it was. Also, having a TR1 from a new II like Blackrock would defo propel us a lot higher than now without any RNS.

Insititutional ownership sitrep (as at cob 31 Oct '21):

Ruffer and Henderson have trimmed their holdings by 1m and 463k, respectively, whilst Fidelity have continued accumulating.

https://www.morningstar.com/stocks/xlon/dddd/ownership

Minor effect on sp I know but the bid in the closing auction's looking quite strong atm. One more day closer to bigger news.

DURHAM, N.C., Nov. 15, 2021 (GLOBE NEWSWIRE) -- CoImmune, Inc., a clinical
stage immuno-oncology company working to redefine cancer treatment using
best-in-class cellular immunotherapies, today announced the appointment of Dr.
Ed Baracchini as chairman of the Company’s board of directors.

“As a member of the CoImmune board of directors, Dr. Baracchini has provided
strong counsel and guidance on many important issues in corporate development
and strategy,” stated Dr. Charles Nicolette, chief executive officer. “In
his new role as chairman, his depth of experience in both biotechnology and
fundraising will provide new levels of insight and guidance as we seek to
advance our novel pipeline of cell-based immunotherapies directed at severe
diseases including acute lymphoblastic leukemia and advanced renal cell
carcinoma. We are also grateful to Dr. Byung Geon Rhee for his service as
chair of our board during a formative period in the growth of CoImmune.”

Dr. Baracchini has extensive experience in structuring and negotiating
research and development partnerships, mergers and acquisitions, and licensing
agreements and has raised a considerable amount of money in private and public
capital markets. He has personally negotiated more than 80 business
transactions with multinational pharmaceutical firms, biotechnology companies,
and prominent universities. He is currently a member of the board of directors
at INmune Bio (NASDAQ: INMB) and 4D Pharma (AIM: DDDD) (NASDAQ: LBPS). From
2020-2021 he was chief business officer at Imago Biosciences and from 2010 to
2018 he was chief business officer at Xencor Inc. He has also held leadership
roles in business development and corporate strategy at Metabasis, Elitra
Pharmaceuticals, Warner-Lambert, Agouron Pharmaceuticals and Ionis
Pharmaceuticals. He earned his BS in microbiology at University of Notre Dame,
a PhD in molecular and cell biology at University of Texas, and his MBA at
University of California, Irvine.

And regarding the timing issue, the accumulating MM should report the completed trade in the after-hours of the following day of the completion latest, is what I believe should happen. Haven't looked it up though. So that possible scenario of buying x amount over x amounts and crossing through thresholds if fine and dandy up to 3% but anything beyond that they ought to be careful with. FCA, albeit mostly timid, have their ways.

I seriously do hope that we're in one of those situations GtIV. Mind you, I've almost always come across block trades (in size rather than percentage). Like 5 million shares at best or at 85p etc, negotiated over the phone with patient capital. Sell-side and prime brokerage get these in quite frequently. The "percentage of a company order" would be fab for us here needless to say but to me personally it seems far fetched tbh.

In the Handbook under 5.8.3:

https://www.handbook.fca.org.uk/handbook/DTR/5.pdf

Holding firm here too. Nigh on impossible for this stock to hit 9.8mil daily volume without institutional involvement. I expect some committed capital has been pouring in rather quietly but after today a TR1 can't be far away.

"Look man, I only need to know one thing – where they are." Vasquez in Aliens (1986)

Cheers Sunny, I shall do exactly that (even though HL's ok in that regard); i.e. putting in high limit orders. Curious to see how today'll pan out.